Question 4

Biology

1 answer:

Gnom [1K]3 years ago

5 0

Answer:

In the lytic cycle, a phage acts like a typical virus: it hijacks its host cell and uses the cell's resources to make lots of new phages, causing the cell to lyse (burst) and die in the process.

Explanation:

Hope this helps.

You might be interested in

3. Which statement concerning an ecosystem is correct?

brilliants [131]

Answer:

C) It involves interactions between biotic and

abiotic factors.

Explanation:

Ecosystems need energy imput, need both consumers and producers, and can exist on land, lakes, rivers and oceans.

6 0

3 years ago

Sleep could be best described as a __________. a. car with the engine started, but parked and idling b. truck driving on the fre

qaws [65]

Answer:

The best answer is A) A car with the engine started, but parked and idling.

Explanation:

This mean are body still breathing and pumping blood but were not aware and cant move.

-Hope This Helps!

-Justin:)

3 0

2 years ago

Critical protein-protein interactions within the CARMA1-BCL10-MALT1 complex: Take-home points for the cell biologist

dolphi86 [110]

Protein-protein interactions within the CARMA1-BCL10-MALT1 complex:

The T-cell receptor and B-cell receptor-dependent NF-B induction and lymphocyte activation are mediated by the CBM complex, which is made up of the proteins CARMA1, BCL10, and MALT1.
Each of the proto-oncoproteins CARMA1, BCL10, and MALT1 is a somatic gain-of-function mutation or chromosomal translocation, and dysregulation of CBM signaling is a characteristic of numerous lymphoid malignancies, including Activated B-cell Diffuse Large B-cell Lymphoma.
Moreover, a number of immunological dysregulation diseases have been linked to both gain- and loss-of-function germline mutations in CBM complex proteins.
Over the past ten years, careful examination of the interactions of CBM components has yielded a wealth of detailed structural knowledge.
Here, we discuss important discoveries about the molecular nature of these protein-protein interactions that have helped the research develop a detailed understanding of how these proteins come together to form high-order filamentous CBM complexes.
Approaches to therapeutic suppression of the CBM complex have thus far centered on obstructing MALT1 protease activity in order to treat lymphoid malignancy and/or autoimmunity.
The structural effects of MALT1 protease inhibitors on significant protein-protein interactions are also reviewed in detail.